What is it about?

We introduced early re-oparation in case of adenoma rests in acromegaly and even intra-operative GH-measurement. This may be hindered by medical pre-treatment. A specific assay makes this possible under Pegvisomant, whereas long-acting somatostatin analogues have to be stopped long-time before surgery.

Featured Image

Read the Original

This page is a summary of: Novel Use of Endogenous GH-Measurement Directly after Transsphenoidal Microsurgery in Acromegaly Treated with Pegvisomant, Experimental and Clinical Endocrinology & Diabetes, June 2013, Thieme Publishing Group,
DOI: 10.1055/s-0033-1347253.
You can read the full text:

Read

Contributors

The following have contributed to this page